4ztg: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Ebola virus nucleoprotein bound to VP35 chaperoning peptide P22121== | ==Ebola virus nucleoprotein bound to VP35 chaperoning peptide P22121== | ||
<StructureSection load='4ztg' size='340' side='right' caption='[[4ztg]], [[Resolution|resolution]] 2.80Å' scene=''> | <StructureSection load='4ztg' size='340' side='right'caption='[[4ztg]], [[Resolution|resolution]] 2.80Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4ztg]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Ebov-may Ebov-may]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZTG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ZTG FirstGlance]. <br> | <table><tr><td colspan='2'>[[4ztg]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Ebov-may Ebov-may]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZTG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ZTG FirstGlance]. <br> | ||
Line 15: | Line 15: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Ebov-may]] | [[Category: Ebov-may]] | ||
[[Category: Large Structures]] | |||
[[Category: Abelson, D M]] | [[Category: Abelson, D M]] | ||
[[Category: Kirchdoerfer, R N]] | [[Category: Kirchdoerfer, R N]] |
Revision as of 11:50, 4 December 2019
Ebola virus nucleoprotein bound to VP35 chaperoning peptide P22121Ebola virus nucleoprotein bound to VP35 chaperoning peptide P22121
Structural highlights
Function[VP35_EBOZM] Acsts as a polymerase cofactor in the RNA polymerase transcription and replication complex. Prevents establishment of cellular antiviral state by blocking virus-induced phosphorylation and activation of interferon regulatory factor 3 (IRF3), a transcription factor critical for the induction of interferons alpha and beta. The mechanism by which this blockage occurs remains incompletely defined, a hypothesis suggests that VP35 dsRNA-binding activity prevents activation of IRF3 by sequestering dsRNA. Also inhibits the antiviral effect mediated by the interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2/PKR.[1] [2] [3] [4] [5] References
|
|